论文部分内容阅读
目的评价经皮肝穿刺射频(RF)消融治疗包膜下肝肿瘤的效用与安全性。方法本研究经伦理委员会批准,所有受试者都签署了知情同意书。181例病人(男79例,女102例,年龄36～85岁)的361个原发或继发(转移的)肝肿瘤进
Objective To evaluate the efficacy and safety of percutaneous transhepatic radiofrequency ablation (RFA) in the treatment of subcapsular hepatic tumors. Methods The study was approved by the Ethics Committee and all subjects signed informed consent forms. A total of 361 primary or secondary (metastatic) liver tumors of 181 patients (79 males, 102 females, ages 36-85 years)